Search Results - "Colinet, Benoit"
-
1
Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT)
Published in PloS one (31-03-2016)“…Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibition is the preferred first-line treatment of advanced adenocarcinoma of the lung that harbors…”
Get full text
Journal Article -
2
An unusual progressive stridor
Published in Breathe (Lausanne, Switzerland) (01-06-2020)“…A 71-year-old man came to our pulmonary consultation with 6 weeks of progressive dyspnoea, hoarseness and, more recently, stridor. His past medical history…”
Get full text
Journal Article -
3
Absence of cross-toxicity between MET inhibitors in a non-small-cell lung cancer with a MET exon 14 skipping mutation
Published in Acta clinica belgica (English ed. Online) (01-04-2024)“…Selective tyrosine kinase inhibitors are proven effective in patients with non-small lung cancer (NSCLC) with a MET exon 14 skipping mutation. The patient…”
Get full text
Journal Article -
4
A phase II single-arm study of induction chemotherapy with cisplatin and gemcitabine followed by concurrent cisplatin and gemcitabine with thoracic radiation for unresectable locally advanced non-small cell lung cancer
Published in Therapeutic advances in medical oncology (01-05-2013)“…Objectives: The aim of this study was to evaluate the efficacy and tolerability of the combination of cisplatin–gemcitabine with concurrent thoracic…”
Get full text
Journal Article -
5
Real-Life Study of Mepolizumab in Idiopathic Chronic Eosinophilic Pneumonia
Published in Lung (01-04-2020)“…Introduction Idiopathic chronic eosinophilic pneumonia (ICEP) is an orphan lung disease characterized by concomitant systemic and local eosinophilia, along…”
Get full text
Journal Article Web Resource -
6
VAC chemotherapy with valproic acid for refractory/relapsing small cell lung cancer: a phase II study
Published in ERJ open research (01-10-2015)“…Salvage chemotherapy (CT) for relapsing or refractory small cell lung cancer (SCLC) remains disappointing. experiments showed that valproic acid increases…”
Get full text
Journal Article Web Resource -
7
Multiple Storiform Collagenomas in the Tracheobronchial Tree of a Patient With a Cowden Syndrome
Published in Journal of bronchology & interventional pulmonology (01-10-2022)Get full text
Journal Article -
8
Osimertinib in patients with advanced/metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer - the Belgian ASTRIS data
Published in Acta clinica belgica (English ed. Online) (01-06-2021)“…Objectives: The aim of ASTRIS, a real-world study, was to assess the safety and efficacy of osimertinib in patients with locally advanced or metastatic (stage…”
Get full text
Journal Article -
9
Ventral Primary Hernia with Liver Content
Published in Case reports in surgery (31-05-2021)“…Background. Herniation of the liver through the anterior abdominal wall is an extremely rare phenomenon. Most cases occur within an incisional hernia (mostly…”
Get full text
Journal Article -
10
Lung Adenocarcinoma Mimicking a Bilateral Cavitary Pneumonia
Published in Journal of the Belgian Society of Radiology (08-06-2022)“…Teaching Point: Failure to recognize unusual radiological presentations of some lung adenocarcinomas can lead to misdiagnosis and/or delay appropriate…”
Get full text
Journal Article -
11
Real-World Treatment Patterns, Epidermal Growth Factor Receptor (EGFR) Testing and Outcomes in EGFR-Mutated Advanced Non-small Cell Lung Cancer Patients in Belgium: Results from the REVEAL Study
Published in Drugs -- real world outcomes (01-06-2021)“…Background Treatment of patients with epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) continues to evolve expeditiously…”
Get full text
Journal Article -
12
A phase III randomised study comparing concomitant radiochemotherapy with cisplatin and docetaxel as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer
Published in Lung cancer (Amsterdam, Netherlands) (01-03-2018)“…•Concurrent radiochemotherapy is the recommended treatment for unresectable stage III NSCLC.•There is no survival difference between induction and…”
Get full text
Journal Article -
13
Transient selective factor X deficiency in a severely burned child
Published in Burns (01-11-2008)Get full text
Journal Article -
14
Abstract CT021: Preliminary clinical results of a therapeutic cancer vaccine PDClung01 in combination with anti-PD-1 in patients (pts) with stage IV NSCLC
Published in Cancer research (Chicago, Ill.) (05-04-2024)“…Background PDC*lung01 (IMP) is a therapeutic cancer vaccine based on an irradiated plasmacytoid dendritic cell line loaded with HLA-A*02:01-restricted peptides…”
Get full text
Journal Article -
15
Abstract 1182: PDClung01: An innovative therapeutic cancer vaccine induces specific immune responses in combination with anti- PD-1 treatment in patients with non-small cell lung cancer
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…We have developed an innovative cancer vaccine for the treatment of advanced NSCLC patients in combination with checkpoint inhibitors. This PDC*lung01 product…”
Get full text
Journal Article -
16
Prospective evaluation of first-line erlotinib in advanced non-small cell lung cancer
Published in PloS one (31-03-2016)“…Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibition is the preferred first-line treatment of advanced adenocarcinoma of the lung that harbors…”
Get full text
Journal Article -
17
Multiple Storiform Collagenomas in the Tracheobronchial Tree of a Patient With a Cowden Syndrome
Published in Journal of bronchology & interventional pulmonology (15-08-2022)Get full text
Journal Article -
18
Prospective Validation Obtained in a Similar Group of Patients and with Similar High Throughput Biological Tests Failed to Confirm Signatures for Prediction of Response to Chemotherapy and Survival in Advanced NSCLC: A Prospective Study from the European Lung Cancer Working Party
Published in Frontiers in oncology (28-01-2015)“…Cisplatin doublets are standard 1st line treatment for advanced non-small cell lung cancer (NSCLC), without accurate predictor for response and survival, but…”
Get full text
Journal Article Web Resource -
19
Epidemiology of the adverse hemodynamic events occurring during “clonidine anesthesia”: A prospective open trial of intraoperative intravenous clonidine
Published in Journal of clinical anesthesia (01-08-1995)“…Study Objective: Determine the hemodynamic consequences of intraoperative clonidine during major abdominal surgery. Design: Prospective open trial. Setting:…”
Get full text
Journal Article -
20